Regencell Bioscience (RGC) has had the highest return since December 31, 2018 by a large-cap US stock, returning 14,399.7%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 14,399.68% |
NVIDIA (NVDA) | 5,407.03% |
Celsius (CELH) | 4,434.16% |
Celestica (CLS) | 3,346.98% |
Galaxy Digital (GLXY) | 3,089.67% |
Fortress Transp & Infra Inv (FTAI) | 2,884.41% |
Comfort Systems USA (FIX) | 2,345.97% |
Super Micro Computer (SMCI) | 2,069.78% |
Tesla (TSLA) | 1,876.13% |
Palantir Technologies (PLTR) | 1,674.9% |
Natera (NTRA) | 1,660.41% |
Lam Research (LRCX) | 1,650.54% |
Nova (NVMI) | 1,646.76% |
Howmet Aerospace (HWM) | 1,630.34% |
KLA-Tencor (KLAC) | 1,612.51% |
Vertiv (VRT) | 1,582.47% |
Summit Therapeutics (SMMT) | 1,526.45% |
Broadcom (AVGO) | 1,514.82% |
Gold Fields Ltd ADR (GFI) | 1,501.81% |
Leonardo DRS, Inc Common Stock (DRS) | 1,468.15% |
Dillard's (DDS) | 1,399% |
Axon Enterprise (AXON) | 1,349.5% |
Quanta Services (PWR) | 1,334.55% |
Carvana (CVNA) | 1,333.72% |
Flex (FLEX) | 1,307.71% |
Large-cap stocks are treated as having a market cap of $10B+.
